36 related articles for article (PubMed ID: 34738625)
21. Egfl7 promotes tumor escape from immunity by repressing endothelial cell activation.
Delfortrie S; Pinte S; Mattot V; Samson C; Villain G; Caetano B; Lauridant-Philippin G; Baranzelli MC; Bonneterre J; Trottein F; Faveeuw C; Soncin F
Cancer Res; 2011 Dec; 71(23):7176-86. PubMed ID: 22037871
[TBL] [Abstract][Full Text] [Related]
22. EGFL7 regulates sprouting angiogenesis and endothelial integrity in a human blood vessel model.
Usuba R; Pauty J; Soncin F; Matsunaga YT
Biomaterials; 2019 Mar; 197():305-316. PubMed ID: 30684886
[TBL] [Abstract][Full Text] [Related]
23. Endothelial Cell Activation Is Regulated by Epidermal Growth Factor-like Domain 7 (Egfl7) during Inflammation.
Pinte S; Caetano B; Le Bras A; Havet C; Villain G; Dernayka R; Duez C; Mattot V; Soncin F
J Biol Chem; 2016 Nov; 291(46):24017-24028. PubMed ID: 27650497
[TBL] [Abstract][Full Text] [Related]
24. Impact of Activation of
Sznurkowski JJ; Żawrocki A; Krawczyńska N; Bieńkowski M; Wasąg B; Biernat W
Medicina (Kaunas); 2022 Apr; 58(5):. PubMed ID: 35630004
[No Abstract] [Full Text] [Related]
25. EGFL7 Mediates BMP9-Induced Sprouting Angiogenesis of Endothelial Cells Derived from Human Embryonic Stem Cells.
Richter A; Alexdottir MS; Magnus SH; Richter TR; Morikawa M; Zwijsen A; Valdimarsdottir G
Stem Cell Reports; 2019 Jun; 12(6):1250-1259. PubMed ID: 31155507
[TBL] [Abstract][Full Text] [Related]
26. EGF repeats of epidermal growth factor‑like domain 7 promote endothelial cell activation and tumor escape from the immune system.
Pinte S; Delfortrie S; Havet C; Villain G; Mattot V; Soncin F
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34738625
[TBL] [Abstract][Full Text] [Related]
27. Role of EGFL7 in human cancers: A review.
de Oliveira C; Gonçalves PG; Bidinotto LT
J Cell Physiol; 2023 Aug; 238(8):1756-1767. PubMed ID: 37490307
[TBL] [Abstract][Full Text] [Related]
28. EGFL7: a unique angiogenic signaling factor in vascular development and disease.
Nichol D; Stuhlmann H
Blood; 2012 Feb; 119(6):1345-52. PubMed ID: 22160377
[TBL] [Abstract][Full Text] [Related]
29. EGFL7: Master regulator of cancer pathogenesis, angiogenesis and an emerging mediator of bone homeostasis.
Hong G; Kuek V; Shi J; Zhou L; Han X; He W; Tickner J; Qiu H; Wei Q; Xu J
J Cell Physiol; 2018 Nov; 233(11):8526-8537. PubMed ID: 29923200
[TBL] [Abstract][Full Text] [Related]
30. miR-126 and miR-126*: new players in cancer.
Meister J; Schmidt MHH
ScientificWorldJournal; 2010 Oct; 10():2090-100. PubMed ID: 20953557
[TBL] [Abstract][Full Text] [Related]
31. Extracellular vimentin as a versatile immune suppressive protein in cancer.
van Loon K; van Breest Smallenburg ME; Huijbers EJM; Griffioen AW; van Beijnum JR
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188985. PubMed ID: 37717859
[TBL] [Abstract][Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]